Lupin
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Inspire Off Western Expressway Kalpataru...Phone Number
+91 2266402323Website
www.lupin.comRevenue
$23.3 MillionStock Symbol
LUPINIndustry
About Lupin
Lupin Org Chart
Is Lupin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Lupin
Check if Lupin has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Lupin recently announced quarterly report
Lupin, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Lupin is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Lupin launches new products
Click to see if Lupin had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Lupin has new funding data
Recommended Actions
Reach out to Masked Content who joined Lupin as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Lupin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lupin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lupin.
Lupin Tech Stack
A closer look at the technologies used by Lupin
Most Recent Scoops
Lupin News & Media
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
MUMBAI, India and NAPLES, Fla., June 4, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizumab,...Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
MUMBAI, India and NAPLES, Fla., June 3, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and its alliance partner Natco Pharma Limited (Natco) today announced the approval from the United States Food and Drug...Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets
MUMBAI, India and NAPLES, Fla., May 29, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026
MUMBAI, India and NAPLES, Fla. and CHICAGO, May 28, 2026 /PRNewswire/ -- Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced that results from its Phase 1a trial evaluating LNP8701, a novel SOS1 inhibitor, have been accepted for publication at...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lupin
Lupins journey is a testament to the potential of human imagination, compassion, and the unwavering pursuit of a better tomorrow. Established by their visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader.... Read More

